Atrs stock alert: halper sadeh llp is investigating whether the sale of antares pharma, inc. is fair to shareholders

New york--(business wire)--halper sadeh llp, an investor rights law firm, is investigating whether the sale of antares pharma, inc. (nasdaq: atrs) to halozyme therapeutics, inc. for $5.60 per share in cash is fair to antares pharma shareholders. halper sadeh encourages antares pharma shareholders to click here to learn more about their legal rights and options or contact daniel sadeh or zachary halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. the investigation conce
ATRS Ratings Summary
ATRS Quant Ranking